Menu Close

Unlocking the Investment Potential of The Hill @ One-North

Unlocking the Investment Potential of The Hill @ One-North 1

The Rise of The Hill @ One-North

The Hill @ One-North is a massive development project that is poised to change the face of Singapore’s biomedical landscapes. This project is sponsored by JTC Corporation, a Singapore government agency that promotes sustainable development and growth in the country’s industrial and commercial sectors. The Hill @ One-North will be home to world-class research facilities, offices, and residential apartments. This bold initiative is designed to foster innovation and collaboration among scientists, academics, and businesses in Singapore’s burgeoning biomedical industry.

Unlocking the Investment Potential of The Hill @ One-North 2

The Biomedical Industry in Singapore

Singapore’s biomedical industry has been growing rapidly in recent years. The government has invested heavily in this sector, recognizing the potential for economic growth and job creation. In 2020, Singapore’s biomedical sector generated around $31 billion in manufacturing output and employed over 24,000 people. With the rise of new technologies, increased funding, and global collaborations, this sector is poised for even greater growth in the years to come.

The Advantages of Investing in The Hill @ One-North

  • Strategic Location: The Hill @ One-North is located in Singapore’s biomedical hub, surrounded by leading research institutions, universities, and hospitals. This location provides a unique opportunity for investors to tap into the expertise and resources of this vibrant ecosystem.
  • World-Class Facilities: The Hill @ One-North boasts state-of-the-art research facilities, advanced laboratories, and cutting-edge equipment. These facilities are designed to meet the needs of top researchers, from bioinformatics and genomics to drug discovery and clinical trials.
  • Tax Benefits: Singapore offers a range of tax incentives to encourage investment in the biomedical sector. For example, companies involved in biomedical research and development activities can enjoy tax deductions of up to 400% of their qualifying expenses.
  • Government Support: Singapore’s government is committed to promoting the growth of the biomedical industry. It has established several initiatives to support this sector, including research grants, funding schemes, and talent development programs.
  • Key Players in The Hill @ One-North

    The Hill @ One-North is a collaborative effort that brings together leading players in the biomedical industry. Here are some of the key players: To discover additional and complementary information on the subject covered, we’re committed to providing a rich educational experience. Read about this third-party analysis.

  • Vertex Pharmaceuticals: This US-based company is a global leader in developing innovative medicines for serious diseases. Its Singapore research center is located at The Hill @ One-North, where it focuses on discovering and developing new therapeutic treatments.
  • Novartis: This Swiss multinational pharmaceutical company has established its Asia-Pacific headquarters at The Hill @ One-North. Its state-of-the-art facility is equipped with advanced technologies for drug development and production.
  • Singapore-MIT Alliance for Research and Technology (SMART): This unique collaboration between Singapore’s government and the Massachusetts Institute of Technology (MIT) conducts cutting-edge research in a variety of fields, including biomedical engineering, infectious diseases, and robotics. Its research center is located at The Hill @ One-North.
  • Conclusion

    The Hill @ One-North represents a unique investment opportunity for those looking to tap into the growing biomedical industry in Singapore. With its strategic location, world-class facilities, tax benefits, and government support, investing in The Hill @ One-North is a smart move for both local and international investors. As this project takes shape, we can expect to see more breakthroughs and innovations in the field of biomedical research, strengthening Singapore’s position as a global leader in this sector.

    Learn more about the topic in the related posts we recommend. Check it out:

    Investigate this in-depth material

    Explore this external study

    Learn from this interesting research